InvestorsHub Logo
Followers 105
Posts 16334
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Tuesday, 12/19/2023 7:11:11 AM

Tuesday, December 19, 2023 7:11:11 AM

Post# of 226
Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CGEN News